期刊文献+

急性心肌梗死合并早发或晚发心房颤动的临床及冠状动脉病变特点分析 被引量:3

Comparison of clinical and coronary angiographic characteristics in acute myocardial infarction patients with new-onset atrial fibrillation in early or later stages
下载PDF
导出
摘要 目的观察急性心肌梗死(AMI)合并早发或晚发心房颤动(房颤)的临床及冠状动脉病变特点。方法分析自2010年6月至2013年6月1358例AMI住院患者,经确诊为AMI合并新发房颤患者88例,根据房颤发生的时间是否在入院24 h以内,分为早发房颤组40例、晚发房颤组48例,比较两组临床特征、冠状动脉病变的差异。结果早发房颤组下壁心肌梗死的比例较高,而晚发房颤组前壁心肌梗死的比例较高(P<0.05);晚发房颤组冠状动脉三支病变、Killip心功能≥2级的发生率及住院期病死率均高于早发房颤组(P<0.05)。结论 AMI合并新发房颤的发生时间与患者的临床特征、梗死相关动脉及预后有关系,可作为评估AMI病情及预后的参考指标。 Objective To explore the clinical and coronary angiographic characteristics in acute myocardial infarction (AMI) patients with new-onset atrial ifbrillation in early or later stages. Methods From Jun. 2010 to Jun. 2013, 1358 cases of AMI were hospitalized in which 88 were proved to have AMI complicated with new-onset atrial ifbrillation. Eligible patients were divided into early onset group (group1, n=40 cases) and the later onset group (group2, n=48 cases) according to the occurrence of atrial ifbrillation within or after 24 hours of admission. The clinical characteristics and the pathological changes of coronary arteries of the two groups were compared respectively. Results The incidence of inferior wall AMI was signiifcantly higher in group 1. The incidence of anterior wall AMI was signiifcantly higher in group 2 (P〈0.05). The incidence of congestive heart failure, the incidence of three-vessel lesions and the in-hospital mortality in group 2 were higher than which in group 1 (P 〈 0.05). Conclusions The new-onset atrial ifbrillation in different stages may be regarded as a useful indicator for evaluating the clinical characteristic and the infarct-related coronary artery lesions and prognosis of patients with AMI.
出处 《中国介入心脏病学杂志》 2014年第6期365-368,共4页 Chinese Journal of Interventional Cardiology
关键词 急性心肌梗死 心房颤动 冠状动脉病变 Acute myocardial infarction Atrial fibrillation Pathological change of coronary arteries
  • 相关文献

参考文献10

  • 1Aronson D, Boulos M, Suleiman A, et al. Relation of C-reactive protein and new-onset atrial fibrillation inpatients with acute myocardial infarction. Am J Cardiol, 2007, 100:753-757.
  • 2Pedersen OD, Abildstrom SZ, Ottesen MM, et al. Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction. Eur Heart J, 2006, 27:290-295.
  • 3Jabre P, Roger VL, Murad MH, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta analysis. Circulation, 2011, 123:1587-1593.
  • 4Kober L, Swedberg K, Mcmurray JJ, et al. Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail, 2006, 8:591-598.
  • 5Stenestrand U, Lindback J, Wallentin L. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from theregister of information and knowledge about Swedish heart intensive care admission. Circulation, 2005, 112:3225-3231.
  • 6Madias JE, Patel DC, Singh D. Atrial fibrillation in acute myocardial infarction: a prospective study based on date from a consecutive series of patients admitted to the coronary care unit. Clin Cardiol, 1996, 19:180-186.
  • 7杨国澍,蔡琳,王新华,施海峰,谭红伟,姜伟峰,顾佳宁,李峥,刘旭.持续性心房颤动线性消融及不同阻滞线与复发的关系分析[J].中国介入心脏病学杂志,2013,21(2):83-87. 被引量:2
  • 8Serrano CV Jr, Ramires JA, Mansur AP, et al. Importance of the time onset of supraventricular tachyarrhythmias on prognosis of patients with acute myocardial infarction. Clin Cardiol, 1995, 18:84-90.
  • 9Sakata K, Kurihara H, Lwamori K, et al. Clinical and prognostic significance of atrial fibrillation in acute myocardial infarction. Am J Cardiol, 1997, 80:1522-1527.
  • 10中华医学会心血管病分会,中华心血管病杂志编辑委员会.急性S段抬高型心肌梗死诊断和治疗指南.中华心血管病杂志,2010,38:675-690.

二级参考文献17

  • 1Nademanee K,McKenzie J, Kosar E, et al. A new approach forcatheter ablation of atrial fibrillation : mapping of theelectrophysiologic substrate. J Am Coll Cardiol, 2004, 43:2044-2053.
  • 2Nademanee K,Schwab MC, Kosar EM, et al. Clinical outcomesof catheter substrate ablation for high-risk patients with atrialfibrillation. J Am Coll Caidiol, 2008,51 :843-849.
  • 3O'Neill MD,Wright M, Knecht S, et al. Long-term follow-up ofpersistent atrial fibrillation ablation using termination as aprocedural endpoint. Eur Heart J, 2009, 30:1105-1112.
  • 4Verma A,Mantovan R,Made L, et al. Substrate and TriggerAblation for Reduction of Atrial Fibrillation ( STAR AF) : arandomized, multicentre, international trial. Eur Heart J, 2010,31:1344-1356.
  • 5Rostock T, Steven D, Hoffmann B, et al. Chronic atrialfibrillation is a biatrial arrhythmia; data from catheter ablation ofchronic atrial fibrillation aiming arrhythmia termination using asequential ablation approach. Circ Arrhythm Electrophysiol,2008,1:344-353.
  • 6Fassini G, Riva S,Chiodelli R, et al. Left mitral isthmusablation associated with PV Isolation: long-term results of aprospective randomized study. J Cardiovasc Electrophysiol,2005, 16:1150-1156.
  • 7Hocini M, Jai's P, Sanders P, et al. Techniques, evaluation, andconsequences of linear block at the left atrial roof in paroxysmalatrial fibrillation: a prospective randomized study. Circulation,2005,112:3688-3696.
  • 8Knecht S,Hocini M, Wright M, et al. Left atrial linear lesionsare required for successful treatment of persistent atrialfibrillation. Eur Heart J, 2008,29:2359-2366.
  • 9Senga M, Fujii E, Sugiura S, et al. Efficacy of linear block atthe left atrial roof in atrial fibrillation. J Cardiol, 2010,55 :322-327.
  • 10Jai's P,Hocini M, Hsu LF, et al. Technique and results of linearablation at the mitral isthmus. Circulation, 2004, 110 : 2996-3002.

共引文献1

同被引文献30

  • 1邱小芩,韦开福.急性心肌梗死新发心房颤动患者心电图P波分析[J].医学信息(医学与计算机应用),2014,0(35):433-433. 被引量:1
  • 2Pedersen OD, Bagger H, Kober L, et al. The occurrence andprognostic significance of atrial fibrillation/lutter following acutemyocardial infarction, TRACE Study group, Trandolapril CardiacEvalution[J]. Eur Heart J, 1999, 20: 748-754.
  • 3Aronson D, Boulos M, Suleiman A, et al. Relation of C-reactiveprotein and new-onset atrial fibrillation inpatients withacute myocardial infarction[J]. Am J Cardiol, 2007, 100: 753-757.
  • 4Jabre P, Roger VL, Murad MH, et al. Mortality associated with atrialfibrillation in patients with myocardial infarction: a systematicreview and meta-analysis[J]. Circulation, 2011, 123(15): 1587-1593.
  • 5Monrrow DA, Antman EM, Charlesworth A, et al. TIMI risk scorefor ST-elevationm yocardial infarctio: a convenient, bedside, clinicalscore for risk Assessment at presentation: an Intmvenous nPA fortreatment of infarcting myocaIdium earlyⅡtrial substudy[J].Circulation, 2000, 102(17): 2031-2037.
  • 6Crenshaw BS, Ward SR, Granger CB, et al. Atrial fibrillation in thesetting of acute myocardial infarction: the GUSTO-I experience[J]. JAm coll Cardiol, 1997, 30: 406.
  • 7Campbell CL, Steinhubl SR. Atrial fibrillation in the setting of acutemyocardial infarction-rregularly irregular treatment[J]. Am Heart J,2008, 155(2): 197-199.
  • 8PodoIecki T, Lenarczyk R, Kowalczyk J, et al. Effect of Type ofAtrial Fibrillation on Prognosis in Acute Myocardial InfarctionTreated Invasively[J]. Am J Cardiol, 2012, 109(12): 1689-1693.
  • 9Schmitt J, Duray G, Gersh BJ, et al. Atrial fibrillation in acutemyocardial infarction: a systematic review of the incidence, clinical features and prognostic implications[J]. Eur Heart J, 2009, 30(9):1038-1045.
  • 10Dilaveris PE, Gialafos EJ. P-wave dispersion: a novel predictor ofparoxysmal catrial fibrillation[J]. Ann Noninvasive Electrocardiol,2001, 6(2): 159-161.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部